Nexkin medical Revenue and Competitors

San Sebastián,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Nexkin medical's estimated annual revenue is currently $3.8M per year.(i)
  • Nexkin medical's estimated revenue per employee is $251,000

Employee Data

  • Nexkin medical has 15 Employees.(i)
  • Nexkin medical grew their employee count by -12% last year.

Nexkin medical's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Nexkin medical?

At Nexkin we are focused on delivering patient-centric digital health solutions. Nexkin Medical specializes in the design, development, manufacture and supply of user-oriented systems, medical devices and solutions for allergology. We have been designing technology to improve allergy testing since 2009, with participation of a team of allergologists, scientists and engineers with various complementary backgrounds. Nexkin Medical encourages innovative thinking and since its inception has developed an active research and development programme. We are always interested in technology and ideas that might lead to new products, or modifications to existing models. We actively collaborate with customers, researchers and the industry to improve patient's lives. Would you like to join the team? Contact us

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3.8M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nexkin medical News

2022-03-22 - Ysium Medical, la nueva 'spin-off' de Vidorreta Design que ...

Entre sus creaciones destacan aparatos como Nexkin, un dispositivo que ayuda al diagnóstico de las alergias; Evernoa, para la detección y...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.7M49-18%N/A
#2
$10.4M6722%N/A
#3
$17.3M11949%N/A